- Home
- MASS vs PRE Comparison
MASS vs PRE Comparison
Compare MASS & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- PRE
- Stock Information
- Founded
- MASS 2012
- PRE 2014
- Country
- MASS United States
- PRE Hong Kong
- Employees
- MASS N/A
- PRE N/A
- Industry
- MASS Medical/Dental Instruments
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- MASS Health Care
- PRE Industrials
- Exchange
- MASS Nasdaq
- PRE Nasdaq
- Market Cap
- MASS 84.3M
- PRE 52.5M
- IPO Year
- MASS 2020
- PRE N/A
- Fundamental
- Price
- MASS $5.79
- PRE $5.19
- Analyst Decision
- MASS Buy
- PRE Buy
- Analyst Count
- MASS 3
- PRE 1
- Target Price
- MASS $5.33
- PRE $9.00
- AVG Volume (30 Days)
- MASS 456.1K
- PRE 10.6K
- Earning Date
- MASS 05-13-2025
- PRE 06-17-2025
- Dividend Yield
- MASS N/A
- PRE N/A
- EPS Growth
- MASS N/A
- PRE N/A
- EPS
- MASS N/A
- PRE N/A
- Revenue
- MASS $59,631,000.00
- PRE $30,621,000.00
- Revenue This Year
- MASS N/A
- PRE $148.70
- Revenue Next Year
- MASS $18.84
- PRE $82.89
- P/E Ratio
- MASS N/A
- PRE N/A
- Revenue Growth
- MASS 18.72
- PRE 40.83
- 52 Week Low
- MASS $1.81
- PRE $3.10
- 52 Week High
- MASS $7.48
- PRE $6.99
- Technical
- Relative Strength Index (RSI)
- MASS 66.62
- PRE 65.84
- Support Level
- MASS $5.01
- PRE $5.07
- Resistance Level
- MASS $5.73
- PRE $5.40
- Average True Range (ATR)
- MASS 0.41
- PRE 0.34
- MACD
- MASS -0.00
- PRE 0.06
- Stochastic Oscillator
- MASS 89.58
- PRE 75.91
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.